Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Apr 6, 2015
Company News
Hyperion Therapeutics Inc, Horizon Pharma deal
...worldwide rights to the pre-prodrug of phenylacetic acid from the Ucyclyd Pharma Inc. subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Oct 20, 2014
Company News
Coronado Biosciences management update
...Medical Corp. subsidiary, formerly VP of dermatology sales and executive director of aesthetics sales at
Medicis Pharmaceutical
...
Read More
BioCentury
|
Oct 20, 2014
Company News
Coronado Biosciences dermatology news
...subsidiary. Maraoui is formerly VP of dermatology sales and executive director of aesthetics sales at
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 11, 2014
Clinical News
Ravicti glycerol phenylbutyrate regulatory update
...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 11, 2014
Clinical News
Gazyva regulatory update
...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 4, 2014
Company News
Ipsen, Nestle deal
...U.S. and Canadian rights to commercialize Dysport, which Valeant gained in its 2012 acquisition of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 4, 2014
Company News
Cosmo Pharmaceuticals S.p.A., Valeant Pharmaceuticals deal
...Cosmo and Valeant amended an April 2012 deal that granted
Medicis Pharmaceutical
Corp. , now part of...
Read More
BioCentury
|
Jun 30, 2014
Clinical News
Ravicti glycerol phenylbutyrate regulatory update
...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Jun 16, 2014
Finance
Biotech rating scheme
...devices, with expertise that includes trial design. 2004-07: VP clinical research and regulatory affairs for
Medicis Pharmaceutical
...
Read More
BioCentury
|
Jun 2, 2014
Company News
Valeant Pharmaceuticals, Nestle deal
...U.S. and Canadian rights to commercialize several products Valeant gained in its 2012 acquisition of
Medicis Pharmaceutical
...
Read More
Items per page:
10
1 - 10 of 150
BioCentury
|
Apr 6, 2015
Company News
Hyperion Therapeutics Inc, Horizon Pharma deal
...worldwide rights to the pre-prodrug of phenylacetic acid from the Ucyclyd Pharma Inc. subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Oct 20, 2014
Company News
Coronado Biosciences management update
...Medical Corp. subsidiary, formerly VP of dermatology sales and executive director of aesthetics sales at
Medicis Pharmaceutical
...
Read More
BioCentury
|
Oct 20, 2014
Company News
Coronado Biosciences dermatology news
...subsidiary. Maraoui is formerly VP of dermatology sales and executive director of aesthetics sales at
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 11, 2014
Clinical News
Ravicti glycerol phenylbutyrate regulatory update
...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 11, 2014
Clinical News
Gazyva regulatory update
...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 4, 2014
Company News
Ipsen, Nestle deal
...U.S. and Canadian rights to commercialize Dysport, which Valeant gained in its 2012 acquisition of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Aug 4, 2014
Company News
Cosmo Pharmaceuticals S.p.A., Valeant Pharmaceuticals deal
...Cosmo and Valeant amended an April 2012 deal that granted
Medicis Pharmaceutical
Corp. , now part of...
Read More
BioCentury
|
Jun 30, 2014
Clinical News
Ravicti glycerol phenylbutyrate regulatory update
...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of
Medicis Pharmaceutical
...
Read More
BioCentury
|
Jun 16, 2014
Finance
Biotech rating scheme
...devices, with expertise that includes trial design. 2004-07: VP clinical research and regulatory affairs for
Medicis Pharmaceutical
...
Read More
BioCentury
|
Jun 2, 2014
Company News
Valeant Pharmaceuticals, Nestle deal
...U.S. and Canadian rights to commercialize several products Valeant gained in its 2012 acquisition of
Medicis Pharmaceutical
...
Read More
Items per page:
10
1 - 10 of 150
Previous page
Next page